Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes

Diabetologia

Volumn 44, Issue 6, 2001, Pages 659-673

  Idris, I ^a   Gray, S ^a   Donnelly, R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Diacylglycerol; Endothelial dysfunction; Insulin resistance; PKC; PKC isoenzymes; PKC ; Protein kinase C; Vascular complications; Vascular permeability

Indexed keywords

ALPHA TOCOPHEROL; DIACYLGLYCEROL; GLUCOSE; INSULIN; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C LAMBDA; RUBOXISTAURIN; UNCLASSIFIED DRUG;

ADIPOCYTE; BLOOD VESSEL PERMEABILITY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RETINA BLOOD FLOW; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; DIABETIC ANGIOPATHIES; DIGLYCERIDES; ENZYME ACTIVATION; HUMANS; HYPERGLYCEMIA; INSULIN; ISOENZYMES; PROTEIN KINASE C;

EID: 0034852862     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051675     Document Type: Review

References (159)

1. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues II
2. Isolation of cDNA clones encoding protein kinase C: Evidence for a protein kinase C-related gene family
3. The molecular heterogeneity of protein kinase C and its implications for cellular regulation
4. Protein kinase C isoenzymes: Divergence in signal transduction?
5. Protein kinase C: Structure, function and regulation; minireview
6. Studies on the phosphorylation of protein kinase C-α
7. The role of protein kinase C in cell surface signal transduction and tumour promotion
8. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C
9. Protein kinase C and lipid signalling for sustained cellular responses
10. 11 and diacylglycerol levels in the aorta and heart of diabetic rats. Differential reversibility to glycaemic control by islet transplantation
11. Insulin leads to a parallel translocation of PI-3-kinase and protein kinase C-ξ
12. Protein kinase C-ξ as a down-stream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes
13. Insulin activates protein kinases C-ξ and -λ by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes
14. Protein kinase C isoforms in human airway smooth muscle cells - A role for PKC-ξ in proliferation
15. Expression of the major isoenzyme of protein kinase C in skeletal muscle, PKC-θ, varies with muscle type and in response to fructose-induced insulin resistance
16. Alterations in the expression and cellular localisation of protein kinase C isozymes ε and θ are associated with insulin resistance in skeletal muscle of the high-fat fed rat
17. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C-θ and alterations in the insulin signalling cascade
18. Characterisation of the mechanism for the chronic activation of diacylglycerol-protein kinase C in diabetes and hypergalactosaemia
19. Comparative study of high-glucose effect on phosphatidylcholine hydrolysis of cultured retinal capillary pericytes and endothelial cells
20. 1,2-diacylglycerol content and its fatty acid composition in thoracic aorta of diabetic rats
21. Synergistic action of diacylglycerol and unsaturated fatty acid for PKC activation: Its possible implication
22. Oleic acid promotes changes in the subcellular distribution of protein kinase C in isolated hepatocytes
23. Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acids
24. Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis
25. Possible role of protein kinase C in the pathogenesis of inborn errors of metabolism
26. Protein kinase C: Mediator or inhibitor of insulin action
27. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: An alteration not due to hyperglycaemia
28. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese Zucker rats
29. Insulin administration in vivo increases 1,2-diacylglycerol in rat skeletal muscle
30. Insulin increases the synthesis of phospholipid and diacylglycerol and protein kinase C activity in rat hepatocytes
31. Five isoenzymes of protein kinase C are expressed in normal and STZ-diabetic rat hepatocytes: Effect of phorbol 12-myristate 13-acetate
32. Increased expression of liver PKC-α in hypoinsulinaemic diabetic rats: A post-translational effect
33. Diacylglycerol/protein kinase C signalling: A mechanism for insulin resistance?
34. PKC directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity
35. Phosphorylation of glycogen synthase by protein kinase C
36. Differential effects of ageing on protein kinase C activity in rat adipocytes and soleus muscle
37. Tissue- and isoform-specific effects of ageing in rats on protein kinase C in insulin-sensitive tissues
38. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - Effects of feeding
39. Tissue-dependent activation of protein kinase C in fructose-induced insulin resistance
40. Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle
41. Glucose-induced phosphorylation on the insulin receptor
42. Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of PKC
43. A possible role for protein kinase C in the regulatory differences between intra-abdominal and subcutaneous human adipose tissue
44. Role of protein kinase C in the regulation of glucose transport in the rat adipose cell
45. I, γ and ε in cells overexpressing the insulin receptor
46. Skeletal muscle lipid metabolism: A frontier for new insights into fuel homeostasis
47. Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in non-diabetic subjects
48. Diet and in vivo insulin action: Of rats and man
49. Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL49 653
50. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and PI-3-kinase activity are decreased in intact skeletal muscle strips from obese subjects
51. A new member of the protein kinase C family, nPKC-θ, predominantly expressed in skeletal muscle
52. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (npKCθ)
53. Is insulin resistance in the spontaneously hypertensive rat related to changes in protein kinase C in skeletal muscle?
54. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance
55. Protein kinase C-ε enhances the inhibitory effect of TNF-α on insulin signalling in HEK293 cells
56. Effect of tumour necrosis factor-α on insulin signal transduction in rat adipocytes: Relation to PKC-β and -ξ translocation
57. Effects of tumour necrosis factor-α on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects
58. Tumour-promoting phorbol esters increase basal and inhibit insulin-stimulated lipogenesis in rat adipocytes without decreasing insulin binding
59. Effects of phorbol esters on insulin receptor function and insulin action in hepatocytes
60. Reciprocal effects of the protein kinase C inhibitors staurosporine and H-7 on the regulation of glycogen synthase and phosphorylase in the primary culture of hepatocytes
61. Acute inhibition of insulin-stimulated glucose transport by the phosphatase inhibitor, okadaic acid
62. Serine/threonine phosphorylation of insulin receptor substrate-1 modulates insulin receptor signalling
63. Effects of knockout of the protein kinase C β gene on glucose transport and glucose homeostasis
64. Activation of protein kinase C (α, β and ξ) by insulin in 3T3/L1 cells
65. Evidence for involvement of protein kinase C (PKC)-ξ and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes
66. Insulin increases mRNA levels of protein kinase C-α and -β in rat adipocytes and protein kinase C-α, -β and -θ in rat skeletal muscle
67. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats
68. Protein kinase C isoforms beta-1 and beta-2 inhibit the tyrosine kinase activity of the insulin receptor
69. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase
70. Protein kinase C isoforms α, δ and θ require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells)
71. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ
72. Protein kinase C mediates hyperglycaemia-induced insulin resistance through serine phosphorylation of IRS-1
73. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells
74. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity
75. The insulin receptor is degraded by specific PKC isoforms
76. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612
77. Protein kinase C modulates the insulin-stimulated increase in Akt1 and Akt3 activity in 3T3-L1 adipocytes
78. Acute and chronic effects of troglitazone on isolated rat ventricular cardiomyocytes
79. Insulin-induced redistribution of GLUT4 glucose carriers in the muscle fibre: In search of GLUT4 trafficking pathways
80. The role of diacylglycerol - Protein kinase C signalling in insulin-stimulated glucose transport
81. Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes
82. 2+ by forskolin and phorbol ester
83. Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta cell
84. Molecular cloning and characterisation of PKC-ι, an atypical isoform of protein kinase C derived from insulin secreting cells
85. Atypical protein kinase C isozyme-ξ mediates carbachol-stimulated insulin secretion in RINm5F cells
86. Regulation of insulin secretion by phospholipase C
87. A receptor subtype
88. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells
89. Correlation of diacylglycerol and protein kinase C activity in rat retina to retinal circulation
90. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids
91. Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors, and agents in development
92. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo
93. Protein kinase C activation and the development of diabetic complications
94. Normalisation of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels
95. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol
96. Protein kinase C isoenzyme expression in sciatic nerves and spinal cords of experimentally diabetic rats
97. Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity
98. d-α-tocopherol prevents the hyperglycaemia induced activation of diacylglycerol-protein kinase C pathway in vascular smooth muscle cell by an increase in DAG kinase activity
99. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E
100. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway
101. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease
102. A new look at the heart in diabetes mellitus: From ailing to failing
103. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project
104. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end-products
105. Induction of endothelin-1 expression by glucose: An effect of protein kinase C activation
106. Regulation of retinal haemodynamics in diabetic rats by increased expression and action of endothelin-1
107. Retinal circulatory abnormalities in type 1 diabetes
108. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: Possible mediation via protein kinase C
109. Impaired nitric oxide release by glomeruli from diabetic rats
110. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells
111. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability
112. Effect of protein kinase C and phospholipase A2 inhibitors on the impaired ability of human diabetic platelets to cause vasodilation
113. 2
114. A novel arachidonic acid-selective cytosolic PLA2 contains a calcium-dependent translocation domain with homology to PKC and GAP
115. Endothelin: Emerging role in diabetic vascular complications
116. 2 release
117. Endothelin-dependent actions in cultured AT-1 cardiac myocytes - The role of the ε isoform of protein kinase C
118. Monocyte-endothelial cell interaction in atherogenesis and thrombosis
119. Fibrinogen promotes monocyte adhesion via a protein kinase C dependent mechanism
120. Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes
121. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kB-dependent
122. Protein kinase C of smooth muscle
123. Glucose-induced vascular smooth muscle dysfunction: The role of protein kinase C
124. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells
125. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin-I in the heart, which are prevented by angiotensin II receptor blockade
126. In vivo phosphorylation of cardiac troponin-I by protein kinase C-βII decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts
127. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
128. Mitogen-activated protein kinases as glucose transducers for diabetic complications
129. Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes
130. II isoform in myocardium causes cardiomyopathy
131. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation
132. Protein kinase C-ξ is critical for mitogenic signal transduction
133. Protein kinase C-ξ mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells
134. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes
135. Growth factors mediate intracellular signalling in vascular smooth muscle cells through protein kinase C-linked pathways
136. Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells
137. Protein kinase C phosphorylates caldesmon-77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial monolayers
138. 1 overexpression augments phorbol ester-induced increase in endothelial permeability
139. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C-α
140. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
141. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
142. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
143. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway
144. Protein kinase C involvement in the regulation of angiogenesis
145. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium
146. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats
147. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells
148. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis
149. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C
150. Vitamin E normalises diacylglycerol-protein kinase C activation induced by hyperglycaemia in rat vascular tissues
151. High-dose vitamin E supplementation normalises retinal blood flow and creatinine clearance in patients with type 1 diabetes
152. (s)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9: 16,21-dimetheno-1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4, 13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333 531) and related analogues: Isozyme selective inhibitors of protein kinase C beta
153. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC-β inhibitor
154. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal haemodynamics in diabetic rats
155. Abnormalities of retinal metabolism in diabetes or experimental galactosaemia: Relationship between protein kinase C and ATPases
156. Inhibition of intraocular neovascularisation caused by retinal ischaemia in pigs by PKC-β inhibition with LY333 531
157. Protein kinase C β-selective inhibitor LY333531 ameliorates abnormal retinal haemodynamics in patients with diabetes
158. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model of type 2 diabetes
159. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in STZ-induced diabetic rats